tetano
Editor, Senior Moderator
Biochim Biophys Acta Mol Cell Biol Lipids
. 2022 Mar 3;159140.
doi: 10.1016/j.bbalip.2022.159140. Online ahead of print.
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?
Rossana Roncato[SUP] 1 [/SUP], Jacopo Angelini[SUP] 2 [/SUP], Arianna Pani[SUP] 3 [/SUP], Rossella Talotta[SUP] 4 [/SUP]
Affiliations
Abstract
Lipid rafts are nanoscopic compartments of cell membranes that serve a variety of biological functions. They play a crucial role in viral infections, as enveloped viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can exploit rafts to enter or quit target cells. On the other hand, lipid rafts contribute to the formation of immune synapses and their proper functioning is a prerequisite for adequate immune response and viral clearance. In this narrative review we dissect the panorama focusing on this singular aspect of cell biology in the context of SARS-CoV-2 infection and therapy. A lipid raft-mediated mechanism can be hypothesized for many drugs recommended or considered for the treatment of SARS-CoV-2 infection, such as glucocorticoids, antimalarials, immunosuppressants and antiviral agents. Furthermore, the additional use of lipid-lowering agents, like statins, may affect the lipid composition of membrane rafts and thus influence the processes occurring in these compartments. The combination of drugs acting on lipid rafts may be successful in the treatment of more severe forms of the disease and should be reserved for further investigation.
Keywords: Anticoagulant drugs; Antiviral drugs; COVID-19; Immunosuppressive drugs; Lipid rafts; Lipid-lowering drugs; Monoclonal antibodies; SARS-CoV-2.
. 2022 Mar 3;159140.
doi: 10.1016/j.bbalip.2022.159140. Online ahead of print.
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?
Rossana Roncato[SUP] 1 [/SUP], Jacopo Angelini[SUP] 2 [/SUP], Arianna Pani[SUP] 3 [/SUP], Rossella Talotta[SUP] 4 [/SUP]
Affiliations
- PMID: 35248801
- DOI: 10.1016/j.bbalip.2022.159140
Abstract
Lipid rafts are nanoscopic compartments of cell membranes that serve a variety of biological functions. They play a crucial role in viral infections, as enveloped viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can exploit rafts to enter or quit target cells. On the other hand, lipid rafts contribute to the formation of immune synapses and their proper functioning is a prerequisite for adequate immune response and viral clearance. In this narrative review we dissect the panorama focusing on this singular aspect of cell biology in the context of SARS-CoV-2 infection and therapy. A lipid raft-mediated mechanism can be hypothesized for many drugs recommended or considered for the treatment of SARS-CoV-2 infection, such as glucocorticoids, antimalarials, immunosuppressants and antiviral agents. Furthermore, the additional use of lipid-lowering agents, like statins, may affect the lipid composition of membrane rafts and thus influence the processes occurring in these compartments. The combination of drugs acting on lipid rafts may be successful in the treatment of more severe forms of the disease and should be reserved for further investigation.
Keywords: Anticoagulant drugs; Antiviral drugs; COVID-19; Immunosuppressive drugs; Lipid rafts; Lipid-lowering drugs; Monoclonal antibodies; SARS-CoV-2.